List of Vermillion, Inc. patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8206934 Methods for diagnosing ovarian cancer	Patent 8206934 was granted and assigned to Vermillion, Inc. on June, 2012 by the United States Patent and Trademark Office.		Vermillion, Inc.	United States Patent and Trademark Office	8206934	June 26, 2012
‌ US Patent 8664358 Predictive markers for ovarian cancer	Patent 8664358 was granted and assigned to Vermillion, Inc. on March, 2014 by the United States Patent and Trademark Office.		Vermillion, Inc.	United States Patent and Trademark Office	8664358	March 4, 2014
‌ US Patent 9274118 Predictive markers for ovarian cancer	Patent 9274118 was granted and assigned to Vermillion, Inc. on March, 2016 by the United States Patent and Trademark Office.	Vermillion, Inc.	Vermillion, Inc.	United States Patent and Trademark Office	9274118	March 1, 2016
‌ US Patent 9846158 Predictive biomarkers for ovarian cancer	Patent 9846158 was granted and assigned to Vermillion, Inc. on December, 2017 by the United States Patent and Trademark Office.	Vermillion, Inc.	Vermillion, Inc.	United States Patent and Trademark Office	9846158	December 19, 2017
‌ US Patent 7993868 Saposin D and FAM3C are biomarkers for alzheimer's disease	Patent 7993868 was granted and assigned to Vermillion, Inc. on August, 2011 by the United States Patent and Trademark Office.		Vermillion, Inc.	United States Patent and Trademark Office	7993868	August 9, 2011
‌ US Patent 10605811 Predictive biomarkers for ovarian cancer		Vermillion, Inc.	Vermillion, Inc.	United States Patent and Trademark Office	10605811	March 31, 2020